The cystic fibrosis airway microbiome
Authors:
- Harvey R. RabinHRHarvey R. Rabin
- Michael G. SuretteMSMichael G. Surette
- 1 November 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 18 (6) , 622-627
Abstract
Culture and molecular approaches have established that lower airway infections are polymicrobial. We consider how this new perspective in cystic fibrosis (CF) may affect treatment choices. Standard clinical microbiology of CF infection exacerbations often fails to provide indications of microbial causes that may drive the onset of exacerbation and the anticipated bacteriologic responses to the usual parenteral antibiotics prescribed as treatment. Antimicrobial responses by nonclassical members of the CF airway microbiome may explain why most patients clinically improve. These other organisms contribute to disease either directly as pathogens missed by conventional microbiology or through synergy with conventional pathogens. With these considerations, therapy may best be guided by directed antibiotic therapy to numerically significant isolates. An example is the Streptococcus milleri group, which we now believe to represent new pathogens that profile the exacerbations of infection in the CF lung and that necessitate specific antibiotic therapy to prevent loss of lung function and reduce frequency of exacerbations. A comprehensive understanding of airway infections offers the potential for improved disease management in CF patients. Accurate quantitative microbiology will be a prerequisite for routine intervention based on the polymicrobial perspective of CF infection exacerbations.Keywords
This publication has 51 references indexed in Scilit:
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Human gut microbiome viewed across age and geographyNature, 2012
- Decade-long bacterial community dynamics in cystic fibrosis airwaysProceedings of the National Academy of Sciences, 2012
- Polymicrobial Interactions: Impact on Pathogenesis and Human DiseaseClinical Microbiology Reviews, 2012
- Bacterial biogeography of the human digestive tractScientific Reports, 2011
- Spatial distribution of microbial communities in the cystic fibrosis lungThe ISME Journal, 2011
- Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosisThe ISME Journal, 2010
- Macrolide and Clindamycin Resistance inStreptococcus milleriGroup Isolates from the Airways of Cystic Fibrosis PatientsAntimicrobial Agents and Chemotherapy, 2010
- Bacterial Community Variation in Human Body Habitats Across Space and TimeScience, 2009
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsProceedings of the National Academy of Sciences, 2008